Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Thyroid Cancer

James Fagin

詹姆斯·法金

MD

🏢Memorial Sloan Kettering Cancer Center(纪念斯隆-凯特琳癌症中心)🌐USA

Chief, Endocrinology Service; Professor of Medicine内分泌科主任;医学教授

68
h-index
1
Key Papers
2
Awards
1
Key Contributions

👥Biography 个人简介

Internationally renowned expert in molecular oncology of thyroid cancer. His research on BRAF and RAS mutations in thyroid carcinogenesis and the development of RAF inhibitor-based therapeutic strategies has fundamentally advanced understanding and treatment of thyroid malignancies.

Share:

🧪Research Fields 研究领域

Thyroid Cancer甲状腺癌
RET InhibitorsRET抑制剂
Differentiated Thyroid Cancer分化型甲状腺癌

🎓Key Contributions 主要贡献

BRAF/RAS Thyroid Oncology

Defined the oncogenic roles of BRAF V600E and RAS mutations in thyroid cancer and demonstrated selective RAF inhibitor strategies in preclinical models, guiding clinical development of BRAF-targeted therapies.

Representative Works 代表性著作

[1]

High prevalence of mutations of the PIK3CA gene in thyroid tumors

Journal of Clinical Endocrinology & Metabolism (2005)

Identified PI3K pathway mutations as oncogenic drivers in thyroid cancer, expanding the molecular target landscape.

🏆Awards & Recognition 奖项与荣誉

🏆American Thyroid Association Sidney H. Ingbar Distinguished Lectureship Award
🏆Endocrine Society Distinguished Scientist Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 詹姆斯·法金 的研究动态

Follow James Fagin's research updates

留下邮箱,当我们发布与 James Fagin(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment